Farmaprojects/Polpharma Group, in collaboration with its partners, has successfully launched Dapagliflozin film-coated tablets in the United Kingdom. As a major diabetes and cardiovascular treatment, the launch represents an important step in addressing two of the most pressing global health challenges. This achievement exemplifies Farmaprojects’ strategic ‘patient-first’ approach, driving better health outcomes and expanding patient access. … Continue reading Farmaprojects launches a major diabetes and cardiovascular treatment